Skip to main content
Fig. 2 | Diabetology & Metabolic Syndrome

Fig. 2

From: GA/HbA1c ratio is a simple and practical indicator to evaluate the risk of metabolic dysfunction-associated fatty liver disease in type 2 diabetes: an observational study

Fig. 2

Comparisons of GA, HbA1C, and GA/HbA1C ratio. A Comparisons of the MAFLD prevalence across the GA/HbA1C ratio groups (P < 0.001 for trend). B Comparisons of GA/HbA1C ratio between the patients with and without MAFLD (P < 0.001). C Comparisons of GA between the patients with and without MAFLD (P < 0.001). D Comparisons of HbA1C between the patients with and without MAFLD (P < 0.001)

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us